Additionally, we identified frequently recurrent mutations of the LNP1, MUC16, PRSS3, and MUC3A genes, highlighting previously undetected genetic alteration in the pathogenesis of EBV+ DLBCL. The gene discussed is LNP1; the disease is diffuse large B-cell lymphoma.